What is a stock summary page? Click here for an overview.
Business Description
Sichuan Goldstone Asia Pharmaceutical Inc
ISIN : CNE100001YX5
Share Class Description:
SZSE:300434: Class ACompare
Compare
Traded in other countries / regions
300434.China IPO Date
2015-04-24Description
Sichuan Goldstone Asia Pharmaceutical Inc is engaged in development and application of steel-reinforced plastic composite pipe technology, providing customers with steel-reinforced plastic composite pipes from pipe structure, production process to construction technology. The company is also engaged in research and development, production and sales of medicines and health products.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 19.12 | |||||
| Equity-to-Asset | 0.85 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 0.32 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 5.51 | |||||
| Beneish M-Score | -2.6 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 15.4 | |||||
| 3-Year FCF Growth Rate | -4.9 | |||||
| 3-Year Book Growth Rate | 6 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 37.25 | |||||
| 9-Day RSI | 36.19 | |||||
| 14-Day RSI | 37.27 | |||||
| 3-1 Month Momentum % | -3.21 | |||||
| 6-1 Month Momentum % | 5.56 | |||||
| 12-1 Month Momentum % | -0.11 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.31 | |||||
| Quick Ratio | 2.67 | |||||
| Cash Ratio | 1.62 | |||||
| Days Inventory | 176.01 | |||||
| Days Sales Outstanding | 29.68 | |||||
| Days Payable | 102.1 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.45 | |||||
| Dividend Payout Ratio | 0.51 | |||||
| Forward Dividend Yield % | 1.45 | |||||
| 5-Year Yield-on-Cost % | 1.5 | |||||
| Shareholder Yield % | -0.4 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 58.28 | |||||
| Operating Margin % | 14.83 | |||||
| Net Margin % | 4 | |||||
| FCF Margin % | 6 | |||||
| ROE % | 1.88 | |||||
| ROA % | 1.53 | |||||
| ROIC % | 3.61 | |||||
| 3-Year ROIIC % | 37.27 | |||||
| ROC (Joel Greenblatt) % | 11.76 | |||||
| ROCE % | 3.46 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 75.5 | |||||
| PE Ratio without NRI | 34.79 | |||||
| Shiller PE Ratio | 83.89 | |||||
| PS Ratio | 2.78 | |||||
| PB Ratio | 1.26 | |||||
| Price-to-Tangible-Book | 1.45 | |||||
| Price-to-Free-Cash-Flow | 58.98 | |||||
| Price-to-Operating-Cash-Flow | 24.83 | |||||
| EV-to-EBIT | 29.55 | |||||
| EV-to-EBITDA | 29.55 | |||||
| EV-to-Revenue | 2.26 | |||||
| EV-to-FCF | 36.41 | |||||
| Price-to-GF-Value | 0.75 | |||||
| Price-to-Projected-FCF | 1.08 | |||||
| Price-to-Graham-Number | 1.5 | |||||
| Price-to-Net-Current-Asset-Value | 4.55 | |||||
| Price-to-Net-Cash | 26.96 | |||||
| Earnings Yield (Greenblatt) % | 3.38 | |||||
| FCF Yield % | 2.25 | |||||
| Forward Rate of Return (Yacktman) % | 22.41 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sichuan Goldstone Asia Pharmaceutical Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,138.781 | ||
| EPS (TTM) (Â¥) | 0.1 | ||
| Beta | 1.58 | ||
| 3-Year Sharpe Ratio | -0.02 | ||
| 3-Year Sortino Ratio | -0.03 | ||
| Volatility % | 28.2 | ||
| 14-Day RSI | 37.27 | ||
| 14-Day ATR (Â¥) | 0.420376 | ||
| 20-Day SMA (Â¥) | 8.308 | ||
| 12-1 Month Momentum % | -0.11 | ||
| 52-Week Range (Â¥) | 6.71 - 11.48 | ||
| Shares Outstanding (Mil) | 401.74 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sichuan Goldstone Asia Pharmaceutical Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sichuan Goldstone Asia Pharmaceutical Inc Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sichuan Goldstone Asia Pharmaceutical Inc Frequently Asked Questions
What is Sichuan Goldstone Asia Pharmaceutical Inc(SZSE:300434)'s stock price today?
The current price of SZSE:300434 is ¥7.55. The 52 week high of SZSE:300434 is ¥11.48 and 52 week low is ¥6.71.
When is next earnings date of Sichuan Goldstone Asia Pharmaceutical Inc(SZSE:300434)?
The next earnings date of Sichuan Goldstone Asia Pharmaceutical Inc(SZSE:300434) is .
Does Sichuan Goldstone Asia Pharmaceutical Inc(SZSE:300434) pay dividends? If so, how much?
The Dividend Yield %  of Sichuan Goldstone Asia Pharmaceutical Inc(SZSE:300434) is 1.45% (As of Today), Highest Dividend Payout Ratio of Sichuan Goldstone Asia Pharmaceutical Inc(SZSE:300434) was 0.51. The lowest was 0.08. And the median was 0.24. The  Forward Dividend Yield % of Sichuan Goldstone Asia Pharmaceutical Inc(SZSE:300434) is 1.45%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers